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In patients with Parkinson’s disease and in animal models of this disorder, neurons
in the basal ganglia and related regions in thalamus and cortex show changes that
can be recorded by using electrophysiologic single-cell recording techniques, including
altered firing rates and patterns, pathologic oscillatory activity and increased inter-neuronal
synchronization. In addition, changes in synaptic potentials or in the joint spiking activities
of populations of neurons can be monitored as alterations in local field potentials (LFPs),
electroencephalograms (EEGs) or electrocorticograms (ECoGs). Most of the mentioned
electrophysiologic changes are probably related to the degeneration of diencephalic
dopaminergic neurons, leading to dopamine loss in the striatum and other basal ganglia
nuclei, although degeneration of non-dopaminergic cell groups may also have a role.
The altered electrical activity of the basal ganglia and associated nuclei may contribute
to some of the motor signs of the disease. We here review the current knowledge
of the electrophysiologic changes at the single cell level, the level of local populations
of neural elements, and the level of the entire basal ganglia-thalamocortical network in
parkinsonism, and discuss the possible use of this information to optimize treatment
approaches to Parkinson’s disease, such as deep brain stimulation (DBS) therapy.
Keywords: Parkinson’s disease, parkinsonism, basal ganglia, electrophysiology, extracellular recording, LFP,
animal models
INTRODUCTION
Parkinson’s disease (PD) is primarily characterized by movement
deficits, but encompasses also many non-motor problems. The
term “parkinsonism” refers to a characteristic constellation of
motor impairments that are associated with PD, including
decreased and slow movement (akinesia and bradykinesia),
muscular rigidity, gait instability, and tremor at rest. The
presence of bradykinesia and at least one other signs is
required for the formal diagnosis of PD (Hughes et al.,
1992).
Parkinsonism results, in large part, from the degeneration of
dopaminergic neurons in the pars compacta of the substantia
nigra (SNc; Bernheimer et al., 1973), and the resulting
reduction in the levels of dopamine in the striatum, the
main synaptic target of SNc axons (Hornykiewicz and Kish,
1987). The loss of dopamine is correlated with profound
changes in the activity of neurons in the basal ganglia-
thalamocortical circuits. In this review, we summarize the
current knowledge of some of the electrophysiological changes
that occur in the basal ganglia and related thalamic and
cortical areas in parkinsonism. We focus on results obtained
with extracellular recordings in parkinsonian animals or in
human PD patients. Studies of functional abnormalities can
also be conducted using non-electrophysiological methods
(for instance, by using markers of metabolism or imaging
techniques). The results of these studies are not covered here
in any detail, but have been discussed in other publications
(e.g., Galvan and Wichmann, 2008; Lindenbach and Bishop,
2013).
CIRCUIT ANATOMY AND PATHOLOGY OF PARKINSON’S
DISEASE
FUNCTIONAL ANATOMY OF THE BASAL GANGLIA-THALAMOCORTICAL
CIRCUITS
The basal ganglia (Figure 1, “Normal”) consist of the neostriatum
(caudate nucleus and putamen), the external and internal
pallidal segments (GPe, GPi), the subthalamic nucleus (STN),
the substantia nigra pars reticulata (SNr), and the SNc. These
structures are part of larger functional and anatomical parallel
circuits that also include areas of the frontal cortex and of
the ventral thalamus. Depending on the function of the frontal
cortical area of origin, these basal ganglia-thalamo-cortical
circuits are designated as “motor”, “associative/cognitive” and
“limbic” (Figure 2, Alexander et al., 1986, 1990; Middleton and
Strick, 2000).
The general anatomical arrangement of the basal ganglia is
similar across these circuits. Glutamatergic excitatory cortical
input reaches the basal ganglia via the striatum and STN, and,
to a lesser extent, via the thalamus. The information is then
transferred to the output nuclei of the basal ganglia, the GPi
Frontiers in Neuroanatomy www.frontiersin.org February 2015 | Volume 9 | Article 5 | 1
Galvan et al. Neuronal activity changes in parkinsonism
FIGURE 1 | Firing rate changes in the basal ganglia-thalamo-cortical
motor circuit in parkinsonism. The yellow box indicates the
interconnected basal ganglia nuclei that receive extrinsic input from the
cortical and thalamic regions. For simplicity some connections have been
omitted from this diagram. The left panel indicates the circuits in the
“Normal” state, and the right shows the overall changes in activity that
have been associated with parkinsonism. Blue and red arrows indicate
inhibitory and excitatory connections, respectively. The thickness of the
arrows corresponds to their presumed activity. Abbreviations: CM,
centromedian nucleus of thalamus; D1 and D2, dopamine receptor
subtypes; GPe, external segment of the globus pallidus; GPi, internal
segment of the globus pallidus; LH, lateral habenula; PF, parafascicular
nucleus of the thalamus; PPN, pedunculopontine nucleus; SC, superior
colliculus; SNc, substantia nigra pars compacta; SNr, substantia nigra pars
reticulata; STN, subthalamic nucleus; VA, ventral anterior nucleus of
thalamus; VL, ventrolateral nucleus of thalamus.
and SNr. The projections from the striatum to the output
nuclei are divided into the monosynaptic “direct” pathway,
and the “indirect” pathway, a polysynaptic projection that
traverses GPe and STN before reaching the output nuclei.
The STN is another major entry station for extrinsic cortical
information into the basal ganglia. The cortico-subthalamic
route, together with its continuation to GPi/SNr has been
termed the “hyperdirect” pathway because information flowing
along this projection reaches the basal ganglia output structures
with a shorter delay than information transmitted along the
direct and indirect corticostriatofugal systems (Nambu et al.,
2002).
GPi and SNr neurons project to the thalamus, the
lateral habenula, and brainstem structures, including the
superior colliculus, and the pedunculopontine nucleus.
There are also thalamic projections to the basal ganglia
which reach primarily the striatum, with lesser projections
to GPe and STN (Sadikot and Rymar, 2009; Smith et al.,
2014a).
The obvious topographic separation of motor and non-motor
functions at the cortical level is maintained throughout the
subcortical course of the cortico-basal ganglia-thalamocortical
circuits(Alexander et al., 1986). As mentioned below, abnormal
activity patterns in the motor circuit are correlated with
the appearance of parkinsonism. This circuit originates in
somatosensory, motor, and premotor cortices, which innervate
the post-commissural putamen, preserving a somatotopic
organization. This area of the striatum projects, in turn, to
motor regions of GPe, STN, GPi and SNr. The output nuclei
send their axons to motor regions of thalamus, specifically to
the ventral anterior and ventrolateral nuclei of the thalamus
(VA/VL), which project back to motor regions of cortex.
The GPi and SNr also send collaterals to the intralaminar
centromedian and parafascicular thalamic nuclei (CM/PF)
FIGURE 2 | Segregated basal ganglia—thalamocortical and basal
ganglia—thalamostriatal functional loops. Information related to each
functional modality is processed through segregated regions of the cerebral
cortex, the basal ganglia and thalamic nuclei. Abbreviations: See Figure 1 and
MD, mediodorsal nucleus; PFdl, dorsolateral extension of the PF; VAmc, part
magnocellular of VA; VApc, part parvocellular of VA; VLc, caudal part of VL;
VLd, dorsal VL; VLo, pars oralis of VL; VLm, medial part of VL (based on
Alexander et al., 1986, 1990; Middleton and Strick, 2000).
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which, in turn, send glutamatergic efferents to the striatum
(Sadikot and Rymar, 2009; Smith et al., 2014a). Of these, the
CM nucleus receives movement-related output from GPi, and
projects to the movement-related area of the striatum (the
putamen), while PF receives largely non-motor-related inputs
from the basal ganglia, and projects to the non-motor caudate
nucleus.
While most basal ganglia structures are composed of either
GABAergic (GPe, GPi and SNr) (Oertel and Mugnaini, 1984;
Smith et al., 1987; Ilinsky et al., 1997) or glutamatergic
(STN) projection neurons (Smith and Parent, 1988), the
striatum contains a large population of GABAergic medium-
spiny projection neurons (MSNs), and a smaller, but functionally
important, proportion of interneurons, including cholinergic
and various types of GABAergic interneurons (Kawaguchi, 1993;
Tepper and Bolam, 2004). Besides these intrinsic sources of
GABA, the striatum also receives GABAergic input from a subset
of GPe neurons (Bevan et al., 1998; Sato et al., 2000; Mallet et al.,
2012; Mastro et al., 2014).
In addition, the striatum receives a dense dopaminergic
innervation from neurons in the SNc. Dopamine is a critical
neuromodulator of striatal activity, acting both presynaptically
and postsynaptically. We will describe its (proposed) actions
in some detail here, because knowledge of the effects of the
physiologic dopamine will facilitate an understanding of the
effects of dopamine loss in PD.
At the presynaptic level, dopamine acts to decrease the
release of glutamate from the terminals of cortical or thalamic
projections, as well as the release of GABA from interneurons
(reviewed in Tritsch and Sabatini, 2012). Postsynaptically,
dopamine modulates the excitability and responsiveness of MSNs
and striatal interneurons (Tritsch and Sabatini, 2012).
Dopamine D1-like and D2-like receptors are differentially
expressed on the direct and indirect pathway MSNs, respectively
(Figure 1, Gerfen et al., 1990). Because these receptor families
are coupled to different second messenger system (through Gas
or Gaolf for D1-like receptors, and Gai or Gao for D2-like
receptors, Tritsch and Sabatini, 2012), activation of D1 receptors
increase the excitability of direct pathway MSNs, and facilitates
long-term potentiation at glutamatergic synapses terminating on
them, while activation of D2 receptors decreases the excitability
of indirect pathway MSNs, and promotes long-term depression
at synapses of the cortical projections terminating on their
dendrites (Surmeier et al., 2011, 2014; Tritsch and Sabatini,
2012).
By increasing activity along the direct pathway, dopamine is
thought to lead to an inhibition of the output nuclei of the
basal ganglia. In contrast, by suppressing the activity of indirect
pathway MSNs, dopamine facilitates GPe-STN transmission, thus
increasing the inhibition of STN neurons (downstream from
GPe) and their projections to GPi and SNr. The combination of
these effects is that GPi and SNr activity is reduced by dopamine
release in the striatum, leading to a reduction of the inhibition
of thalamocortical projection neurons that receive the input
from these nuclei. The differential dopaminergic modulation
of the strength of synapses on direct and indirect pathway
MSNs has been proposed to be relevant for the formation
of reward-based procedural memory. The general functional
model of the interactions between direct and indirect pathway
in the regulation of motor activity was proposed decades ago
(Figure 1, Albin et al., 1989; DeLong, 1990), and has received
strong experimental support in the last few years (Kravitz et al.,
2010, 2012; Cui et al., 2013; Freeze et al., 2013; Sano et al.,
2013).
LOSS OF DOPAMINE AND PLASTIC CHANGES IN THE BASAL GANGLIA
IN PD
In PD, the dopaminergic nigrostriatal pathway progressively
degenerates. The dopaminergic projections to the sensorimotor
striatum are affected more strongly than those to the associative
and limbic striatal regions, contributing to the preponderance
of movement problems in PD (Kish et al., 1988; Brooks
et al., 1990). The loss of striatal dopamine is associated
with morphological (non-dopaminergic) changes throughout
the basal ganglia, including a reduction in the density of
dendritic spines of MSNs in the striatum and alterations in
intrastriatal and pallido-subthalamic connectivity, as we discuss
below.
Although the loss of dopaminergic SNc cells remains the
best known pathological feature of PD, it is clear that other
types of neurons also degenerate, including neurons in the
serotonergic raphe nuclei, the noradrenergic locus coeruleus,
the olfactory tubercle, the intralaminar nuclei of the thalamus,
and regions of the cerebral cortex and the peripheral nervous
system (Braak and Braak, 2000; Braak et al., 2006; Sulzer and
Surmeier, 2013). It is still not well understood how these
changes in the brain stem, which occur relatively early in the
disease, contribute to the motor and non-motor manifestations
of parkinsonism.
TECHNIQUES USED TO STUDY PATHOPHYSIOLOGIC
CHANGES IN PARKINSONISM
ANALYTICAL APPROACHES TO EXTRACELLULAR RECORDINGS AND
DEFINITION OF TERMS
Most electrophysiologic in vivo recordings utilize extracellular
recording methods, thus reflecting electrical potentials at the sites
of electrodes that are positioned in the extracellular space, at
some distance from the sources of the electrical activity, i.e.,
neuronal cell bodies or axons. The principal contributors to the
recorded potentials are neuronal events in which ions are moving,
i.e., action potentials and synaptic currents. The former can be
detected as spikes in extracellular recordings, while the latter are
recordable (at least in principle) as low-frequency fluctuations of
recorded potentials.
ANALYSIS OF SINGLE CELL DISCHARGE (ACTION POTENTIALS)
The shape of individual action potentials is heavily dependent
on the distance of the recording site from the current-
generating source, and the geometric arrangement of the two.
Figure 3 shows examples of traces obtained during extracellular
recordings of single neurons in the basal ganglia of monkeys.
The analysis of neuronal action potential activity focuses
therefore mostly on the timing of these potentials, and is
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FIGURE 3 | Examples of extracellular recordings of individual neurons
in the GPe, GPi and STN of monkeys in normal conditions and after
MPTP treatment. Arrows indicate examples of bursts in an STN neuron.
Horizontal line represents 1 s.
conventionally expressed in the form of inter-spike intervals
(ISIs).
The most basic parameters that can be provided by an analysis
of ISIs from an individual neuron are the static firing rate, along
with measurements of the variability of discharge, such as a
calculation of the coefficient of variation of ISIs, and assessments
of the distribution of the ISIs (e.g., Kaneoke and Vitek, 1996).
Other analyses examine the preponderance of specific firing
patterns, specifically bursts of action potentials. Such bursts are
intuitively defined as sudden episodic unexpected accelerations
in discharge rates, and analyzed by a variety of formal burst
detection algorithms (Grace and Bunney, 1984; Legendy and
Salcman, 1985; Aldridge and Gilman, 1991; Wichmann and
Soares, 2006; Shimo and Wichmann, 2009).
Another set of features that can be conveniently studied
is oscillatory activity. When applied to recordings of spiking
activity of single neurons, the term “oscillation” is used to
describe periodic fluctuations in the instantaneous firing rate of
the neuron. Oscillatory activity can be most easily analyzed by
frequency-domain methods, including global or time-resolved
power spectral analyses of a neuron’s discharge. Oscillatory
activity is often grouped into larger frequency bands, based on
conventions from the EEG literature, where rhythmic activity
within specific frequency ranges is found in certain distribution
patterns in scalp recordings, or is thought to have biological
significance. Such frequency bands include the delta band (below
4 Hz), the theta band (4–8 Hz), the alpha band (8–13 Hz), the
beta band (13–30 Hz) and the gamma band (above 30 Hz). The
use of these band designations has led to much confusion in
the field. One problem is that splitting the frequency spectrum
in the EEG-based way may not be useful for other types of
brain recordings. Many researchers therefore break the larger
frequency ranges into smaller ones (such as the “low-beta” and
“high-beta” band), or use the terminology loosely (for instance,
using the term “beta band” for oscillations that encompass parts
of the classical alpha- and beta bands). Another reason that
argues against the unquestioning use of the traditional band
descriptions is that bands of specific biological or pathological
significance may differ between species, so that beta band
oscillations in one species may be equivalent to oscillations in
other bands in another (discussed in ref. Stein and Bar-Gad,
2013).
Oscillations of firing can occur with or without bursting
(Wichmann and Soares, 2006; Wichmann and Dostrovsky, 2011).
When slow oscillations occur in the form of periodically recurring
bursts, this may represent the coupling of two different oscillatory
phenomena (the amplitude of high frequency oscillations within
the bursts is modulated by the phase of the low oscillation
represented by the grouping of bursts), as is discussed to also
be a prominent feature of cortical field potential recordings in
parkinsonian patients (de Hemptinne et al., 2013).
Time domain measures (such as firing rates) and frequency
domain measures (such as power spectra) are not sensitive to
“nonlinear” features of discharge. The analysis of such non-linear
features remains currently in its infancy (e.g., ref. Rodríguez et al.,
2003; Darbin et al., 2006; Dorval et al., 2008), and is an interesting
area of exploration.
Another level of analysis of single cell discharge is that of
examination of the relatedness of activity patterns of multiple
neurons. A commonly used time-domain technique is to compute
the cross-correlation, a measure that examines the likelihood of
firing in one neuron at pre-determined time intervals before or
after another cell’s firing. If oscillatory activity is the focus of the
analysis, frequency-domain techniques (such as cross-spectra or
coherence measurements) can also be applied.
ANALYSIS OF ELECTRICAL ACTIVITY OF NEURONAL POPULATIONS
Field potential recordings (including recordings of local
field potentials (LFPs), electrocorticograms (ECoGs), and
electroencephalograms (EEGs)) offer a rich source of
information. It is generally accepted that LFPs are generated
by transmembrane flow of current, and thus reflect synaptic
activity within a population of neurons in an area several
hundred micrometers in diameter around the electrode (Buzsáki
et al., 2012) (but see Kajikawa and Schroeder, 2011). While
relatively easy to record, the interpretation of these data
is not straightforward. Field potential recordings are most
often analyzed using frequency domain analysis methods,
comparing the spectral content of the signals in different
behavioral states. Another use of these signals is to analyze
the presence of stimulation- or event related potentials, i.e.,
synaptic potentials related to electrical stimulation of the tissue,
or potentials that precede or follow a behavioral event. Individual
evoked potentials are often not visible, so that averaging
techniques have to be used to extract stereotypically recurring
waveforms.
Field potential signals recorded simultaneously at different
locations within the brain can also be used for cross-spectral
or coherence analyses which can provide information on the
coupling of activity of brain regions. Phase shifts in such studies
have been used to identify causality relationships, or to determine
the direction of information flow within the network under study.
EXTRACELLULAR RECORDINGS IN HUMANS
In recent years, functional neurosurgical interventions, such
as lesioning or DBS procedures, have been increasingly used
to treat patients with PD. The placement of lesions or DBS
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electrodes in the brain is often done guided by intraoperative
electrophysiologic recordings. Microelectrode recordings from
these surgeries have been extensively used to analyze the
activity of the basal ganglia and related cortical and thalamic
structures in PD patients. In addition, researchers have also
used the implanted DBS electrodes as (macro-) electrodes to
record LFPs intraoperatively, or in the immediate postoperative
period.
Recordings in humans suffer from the unavoidable limitation
that there are no available recordings in healthy subjects to use as
controls. In some cases, recordings from patients with other basal
ganglia-related neurological conditions (e.g., essential tremor,
dystonia) are used for comparison instead.
ANIMAL MODELS OF PARKINSON’S DISEASE
Animal models of PD can be divided into several categories,
including models that seek to replicate some of the genetic
abnormalities that can lead to parkinsonism (Dawson et al.,
2010; Blesa et al., 2012); models that attempt to mimic the
spread of pathology (such as the intraparenchymal infusion of
alpha-synuclein oligomers, e.g., Bezard et al., 2013), models that
use pharmacological compounds to acutely deplete dopamine
or to antagonize dopaminergic transmission (Bezard and
Przedborski, 2011), and models that utilize neurotoxins that
damage dopaminergic brain neurons (Beal, 2001; Dauer and
Przedborski, 2003; Blesa et al., 2012). Electrophysiologic studies
have heavily relied on the toxin models, so, to a large extent,
our knowledge of the “pathophysiology of the parkinsonian
state” is a description of the consequences of dopamine cell
loss.
The two most common toxins used to create animal models
of PD are 6-hydroxydopamine (6-OHDA) and 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP). Other toxins that
have been described include pesticides and herbicides such as
rotenone and paraquat (Betarbet et al., 2000; Hirsch et al.,
2003; Thiruchelvam et al., 2003; Bové et al., 2005; Blesa et al.,
2012). 6-OHDA was the first compound used to selectively
lesion dopaminergic pathways (Ungerstedt, 1968). This toxin
is injected directly in the brain parenchyma, targeting either
the SNc itself, at the level of the dopaminergic terminals
in the striatum or in the median forebrain bundle, which
carries ascending dopaminergic projections to the forebrain
(Schwarting and Huston, 1996b). Most frequently, 6-OHDA
injections are done unilaterally, while the contralateral side
serves as an (imperfect) control (Ungerstedt, 1968; Schwarting
and Huston, 1996a,b). The toxin is effective in rats, mice,
monkeys and other species, but has been most frequently
used in rats. Dopamine depletion after unilateral injection
of 6-OHDA results in motor asymmetry which can be
easily quantified with behavioral methods (Ungerstedt and
Arbuthnott, 1970; Ungerstedt, 1971; Schwarting and Huston,
1996a).
MPTP was discovered to induce dopamine loss in the
striatum in the early 1980’s, when a group of drug users
developed parkinsonism after accidentally self-administering the
toxin (Langston et al., 1983). Shortly after this discover, MPTP
was shown to produce irreversible phenotypically convincing
parkinsonism in monkeys as well (Burns et al., 1983; Langston
et al., 1984; Langston and Irwin, 1986), which can be alleviated
by dopaminergic agonists (e.g., Nomoto et al., 1985; Nomoto
and Fukuda, 1993), deep brain stimulation (DBS, e.g., Benazzouz
et al., 1993; Johnson et al., 2009; Rosin et al., 2011; Vitek
et al., 2012) and other antiparkinsonian treatments. In monkeys,
MPTP is most commonly administered by systemic injection,
resulting in bilateral parkinsonism (Przedborski et al., 2001).
Daily recurring treatment with high-dose MPTP results in
rapidly evolving severe parkinsonism, while less frequent chronic
administration of small doses of MPTP for a prolonged period of
time (for instance, weekly injections for several months) results
in slowly developing parkinsonism (Albanese et al., 1993). The
latter model has been useful in studying the progression of
electrophysiological changes in the basal ganglia in relation to the
appearance of motor deficits (Devergnas et al., 2014). Another
method of applying MPTP is administration of the toxin via
intracarotid infusion, resulting in hemiparkinsonism (Bankiewicz
et al., 1986).
MPTP can also induce degeneration of dopaminergic neurons
in mice and rats, although, much higher doses of the toxin
are needed than those required for monkeys (Chiueh et al.,
1984; Heikkila et al., 1984; Kopin and Markey, 1988; Giovanni
et al., 1994a,b). MPTP treatment in rodents tends to have more
variable and unstable behavioral outcomes, and is therefore not
commonly used for pathophysiologic studies.
CHANGES IN NEURONAL ACTIVITY IN PARKINSONISM
Early studies of the electrophysiologic alterations in MPTP-
treated monkeys described mostly changes in the firing rates
of individual neurons after dopamine depletion (Filion, 1979;
Miller and DeLong, 1987, 1988), including decreases in
firing rate in GPe neurons, and increased firing in STN,
GPi and SNr cells. These modifications in firing rates are
accompanied by changes in firing patterns, such as an increased
tendency of neurons to fire in bursts of action potentials,
enhanced oscillatory (rhythmic) activity within each nucleus and
among structures, and increased synchrony among neighboring
neurons.
In the following sections we will describe in more detail the
changes in neuronal firing at the single cell and population
levels for each basal ganglia structure, as well as for the
associated cortical and thalamic regions. Although each nucleus
will be presented separately, it is important to keep in mind
that parkinsonian-related changes are the result of network
alterations, thus affecting simultaneously all elements of the basal
ganglia thalamocortical circuitry. Table 1 shows a summary of the
changes reported for each structure.
STRIATUM
The original “rate” model of the basal ganglia dysfunction in
PD (Figure 1, “Parkinsonism”, Albin et al., 1989; DeLong, 1990),
proposed that striatal MSNs that give rise to the direct or indirect
pathway are differentially affected by the striatal dopamine loss in
PD. While direct pathway neurons reduce their firing rate, those in
the indirect pathway increase their activity. As a result, the firing
in GPe neurons is reduced, which leads to disinhibition of STN
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neurons and, subsequently, excessive excitation of STN targets
(GPi and SNr). The increased activity of GPi and SNr neurons is
further reinforced by the lack of inhibition from direct pathway
neurons. The final outcome of these changes is that the basal
ganglia exert a greater than normal inhibition on their thalamic
and brainstem targets.
Evidence in favor of increased activity of some neurons in
the striatum was found in parkinsonian rats and monkeys (Chen
et al., 2001; Liang et al., 2008). By using antidromic stimulation
or juxtacellular labeling, studies in 6-OHDA treated rats have
identified MSNs from the direct or the indirect pathway. These
results indicate that, after dopaminergic depletion, direct pathway
MSNs are less active, while the spontaneous firing of indirect
pathway MSNs is increased (Mallet et al., 2006; Kita and Kita,
2011). The changes in firing rate in MSNs could be, at least
in part, a consequence of changes in corticostriatal projections
rather than an intrinsic change in activity, since cortical input
to direct pathway MSNs (identified by showing antidromically
mediated responses to stimulation of the SNr) show decreased
spontaneous activity in 6-OHDA treated rats (Mallet et al., 2006),
while inputs to neurons that did not respond antidromically to
the SNr stimulation (presumed to be indirect pathway MSNs)
were unchanged. It is not clear whether this finding also applies to
primates, as studies in monkeys have suggested that corticostriatal
projection neurons show few (if any) changes in activity in
the parkinsonian state (Pasquereau and Turner, 2011). The
rate model has recently received additional support from the
application of optogenetic techniques in parkinsonian mice, in
which selective activation of opsin-expressing direct pathway
MSNs alleviated the motor deficits resulting from dopamine
depletion (Kravitz et al., 2010). This study, however, does not
provide direct evidence that low activity of direct pathway MSNs
caused the motor deficits.
Due to the low number of interneurons in the striatum,
changes in the electrical activity of these neurons in parkinsonism
have been studied to a very limited extent. A specific group of
cells, however, the tonically active neurons (TANs presumed
to be cholinergic interneurons, Goldberg and Reynolds, 2011),
has received considerable attention. These cells have a regular
tonic firing at rest, a wide action potential, and a stereotypic
electrophysiological response to rewarding events (Apicella,
2002). After MPTP treatment, the number of TANs showing this
characteristic response to reward was drastically reduced, and a
large proportion of TANs develop abnormal oscillatory activity
around 16 Hz, while the already high degree of correlation
between these neurons was slightly increased (Raz et al., 1996).
Few studies have analyzed parkinsonism-related changes in
oscillatory activities in LFP signals in the striatum. In mice,
spectral power in the delta and beta ranges was increased in
LFPs recorded in the dorsal striatum during pharmacologically-
induced acute akinesia, and such increases were reversed by
administration of L-DOPA (Costa et al., 2006). While intrastriatal
blockade of D2- and D1-receptors induce severe akinesia, only
blockade of D2-receptors increases delta and beta oscillations
and decreases gamma activity in the striatum (Burkhardt
et al., 2009). Other studies have suggested that the effect of
dopamine depletion on LFP oscillations in the striatum may be
task- and learning-dependent (Lemaire et al., 2012), and that
it is strongly influenced by oscillatory activity in the cortex, as
shown by simultaneous recordings of striatal LFPs and EEGs
(Courtemanche et al., 2003; Berke et al., 2004).
The parkinsonian state has frequently been associated with
alterations in the somatotopic organization of the basal ganglia-
thalamo-cortical circuits. In the striatum of parkinsonian rodents,
there is a disruption of the normal organization of striatal neurons
that response to sensory inputs (Cho et al., 2002). This finding
may indicate that cortical-striatal inputs are abnormal (perhaps
related to the morphological changes discussed below), or could
reflect pathological processing of information within the striatum
itself.
Several morphological changes occur in the striatum after
dopaminergic depletion and may contribute to the appearance
of abnormal activity patterns in this nucleus. A major alteration,
first described in 6-OHDA rats and later in PD patients and
MPTP-treated monkeys, is the loss of dendritic spines of MSNs
(Ingham et al., 1989; Stephens et al., 2005; Zaja-Milatovic et al.,
2005; Day et al., 2006; Villalba et al., 2009). Since the dendritic
spines on MSNs are the main recipients of cortico-striatal
(and a proportion of thalamo-striatal) afferents, it is likely
that the spine loss affects glutamatergic transmission in the
striatum (Smith and Villalba, 2013). As studied in MPTP-treated
monkeys, the remaining spines, along with the corticostriatal
and thalamostriatal terminals that contact them, have an
increased volume compared to that found in normal animals,
which may signify increased activity at these synapses (Villalba
and Smith, 2011). Studies in 6-OHDA treated mice have also
demonstrated that the dendritic arborization is reduced in
both direct and indirect pathway MSNs (Fieblinger et al., 2014)
(These morphological alterations are accompanied by functional
changes, as demonstrated recently in in vitro studies, which show
that after dopaminergic lesions with 6-OHDA the intrinsic and
dendritic excitability of indirect pathway MSNs was lower, while
the intrinsic excitability of direct pathway MSNs was increased
(Fieblinger et al., 2014), compared to the normal state. These
changes were interpreted as homeostatic adaptations that could
contribute, in early stages of parkinsoninsm, to keep a balance
activity of both striatal patwhays, but that are insufficient in later
stages (Mallet et al., 2006). Such plastic changes remain to be fully
explored in in vivo animal models of PD (Ma et al., 2012).
Other plastic changes in striatal connectivity have been
described in parkinsonian rodents. Studies in transgenic mice
showed that collateral connections across MSNs of direct and
indirect pathway are reduced by dopamine depletion (Taverna
et al., 2008), while fast-spiking GABAergic striatal interneurons
selectively increase the number of connections established with
indirect-pathway MSNs (Gittis et al., 2011). These changes could
enhance the degree of synchronization among striato-pallidal
MSNs, and could induce alterations in the activity of the target
regions. These plastic changes, however, have not yet been
described in primates.
GPe
The GPe strongly influences the activity of almost all of the other
basal ganglia structures. Early studies in MPTP-treated monkeys
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reported that the average firing rate of GPe neurons was lower
in MPTP-treated monkeys than in normal animals (Miller and
DeLong, 1987, 1988). This observation has been corroborated
in primate and rodent models of PD (Figure 3, Pan and Walters,
1988; Filion and Tremblay, 1991; Heimer et al., 2002; Soares
et al., 2004; Mallet et al., 2008a). Recordings in PD patients found
that the firing rates of GPe neurons were similar to that found
in MPTP-treated monkeys (Hutchison et al., 1994; Sterio et al.,
1994).
The reduced activity of GPe neurons after dopaminergic
depletion could result from an increased activity of indirect
pathway MSNs, as the “rate” model would predict (Figure 1,
“Parkinsonism”). This view has also been incorporated into some
of the models of basal ganglia dysfunction in the parkinsonian
state (Terman et al., 2002). An alternative possibility is that
reduced pallidal activity could result from a loss of autonomous
pace making activity of these neurons after dopamine depletion.
This idea is supported by studies in rodent models of
parkinsonism in which a proportion of GPe neurons was found
to show reduced spontaneous activity (Chan et al., 2010). In these
studies, the number of “silent” GPe neurons correlated with the
severity of the motor deficits.
In addition to the decreased firing rate, the incidence of
burst discharges is increased in GPe neurons, as reported in
MPTP-treated monkeys (Soares et al., 2004; Wichmann and
Soares, 2006) and 6-OHDA treated rodents (Vila et al., 2000;
Ni et al., 2001; Breit et al., 2007). In PD patients, there was
a high degree of bursting in GPe neurons, reminiscent of
that seen in MPTP-treated monkeys (Hutchison et al., 1994;
Magnin et al., 2000). Also, individual neurons with oscillations
in the (approximately) 3–8 and 8–15 Hz frequency bands are
more frequently found in GPe of MPTP-treated than in normal
monkeys (Raz et al., 2000; Soares et al., 2004). A similar
observation has been made in the GP of 6-OHDA treated rats
(Magill et al., 2001).
Furthermore, the normally uncorrelated activity of
neighboring GPe neurons (Nini et al., 1995; Bar-Gad et al.,
2003) becomes more synchronized after MPTP treatment
(Nini et al., 1995; Raz et al., 2000; Heimer et al., 2002; Morris
et al., 2005). The parkinsonian state is similarly associated
with increased synchrony of neuronal activity in the pallidum
in rodents (see below), as well as in most of the other basal
ganglia structures. While the cause of the increased synchrony
remains under investigation, it appears to be a pervasive
feature of basal ganglia activity in parkinsonism that may
contribute (or even underlie) other firing abnormalities, such
as the appearance of oscillatory activity patterns or the finding
of less specific sensory responses of neurons in the motor
circuit (Rothblat and Schneider, 1995; Schneider and Rothblat,
1996; Boraud et al., 2000; Cho et al., 2002; Prokopenko et al.,
2004).
Several recent rodent studies have demonstrated considerable
heterogeneity among GPe neurons, suggesting distinctive patterns
of projections, protein expression and electrophysiological
activity (Sato et al., 2000; Kita, 2007; Mallet et al., 2008a, 2012;
Mastro et al., 2014). Studies in rats have defined two major GPe
neuronal populations with opposing phase relationships with
cortical oscillatory activity, so-called prototypic and arkypallidal
cells (Zold et al., 2007a,b; Mallet et al., 2008a, 2012). Compared
with controls, the level of synchrony of firing between prototypic
or arkypallidal cells, and between each of these groups and
cortical activity is increased after 6-OHDA treatment (Mallet
et al., 2008a; Zold et al., 2012). It has recently been proposed
that these two types of GPe neurons, and the connections
they establish among themselves and with the rest of the basal
ganglia, may have an important role in the development of
the pathological oscillations in parkinsonism (Nevado-Holgado
et al., 2014). It is not (yet) clear whether these rodent findings
can be generalized to primates. In the early reports of primate
GPe electrophysiological activities, DeLong described neurons
with high-frequency firing rates interspersed by pauses, and
a second, less frequently encountered, type of neurons with
low frequency discharge and bursts (DeLong, 1971). It has
been suggested that these neuronal types might correspond,
respectively to the prototypic and arkypallidal types described
in rodents (Mallet et al., 2012), but the parallel remains
unclear.
As in the striatum, dopamine depletion appears to be
associated with morphologic and functional changes in
connectivity in GPe. Thus, intrapallidal collaterals, which
seem to exert only weak inhibition among neighboring neurons
under normal conditions (Bar-Gad et al., 2003) appear to be
functionally strengthened in 6-OHDA treated rats (Miguelez
et al., 2012; Nevado-Holgado et al., 2014), and there is an increase
in the abundance and strength of synaptic contacts between GPe
and STN after dopaminergic depletion (Fan et al., 2012). It is
not clear how these plastic changes are triggered. They may be
an adaptive response, acting to reduce excessive STN activity
(see below), at the price of reinforcing aberrant interneuronal
synchronization.
STN
Based on the initial finding that the mean firing rate of STN
neurons is increased after MPTP-treatment in monkeys (Miller
and DeLong, 1987; Bergman et al., 1994), later corroborated in
several primate and rodent studies (Hassani et al., 1996; Bezard
et al., 1999; Vila et al., 2000; Magill et al., 2001; Soares et al., 2004),
most authors agree that PD is associated with excessive activity in
the STN. This concept has strongly influenced the development of
models of changes in the basal ganglia thalamocortical circuit in
parkinsonism, and the development of surgical strategies for PD
(DeLong and Wichmann, 2012).
While increased firing of STN neurons is considered a
hallmark of the pathological electrical activities in parkinsonism,
other changes in firing activities in the STN may be similarly
important. For instance, similar to pallidal neurons, STN
neurons show increased bursting, in parkinsonian animals,
and probably also in parkinsonian patients (Figure 3,
Bergman et al., 1994; Levy et al., 2000; Soares et al., 2004;
Wichmann and Soares, 2006; Steigerwald et al., 2008;
Tachibana et al., 2011). Bursting-related measures, such as
the intra-burst firing rate of neurons, are among the most
discriminative features of parkinsonism in parkinsonian monkeys
(Sanders et al., 2013) and correlate strongly with the
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severity of parkinsonism in patients with PD (Sharott et al.,
2014).
The proportion of neurons in STN with oscillatory firing is
also markedly increased in the parkinsonian state, particularly
in the 3–8 and 8–15 Hz frequency ranges in MPTP-treated
monkeys (Bergman et al., 1994; Soares et al., 2004; Rivlin-
Etzion et al., 2006; Moran et al., 2012; Galvan et al., 2014).
These oscillations are coherent with those of neurons that are
simultaneously recorded in the STN targets, GPe and GPi (Moran
et al., 2012). In PD patients, many STN neurons also show
oscillations, but at higher (15–30 Hz) frequencies (Levy et al.,
2002b; Weinberger et al., 2006). Neurons with oscillatory activity
are more likely to exhibit, in addition, an increase in tonic
firing (Bergman et al., 1994; Deffains et al., 2014). Studies in
humans have also shown that STN neurons in PD patients
with limb tremor tend to show synchronized firing (Levy et al.,
2000).
Numerous studies have analyzed the characteristics of LFP
signals recorded from the STN area in patients with advanced
parkinsonism. Such recordings can conveniently be made, using
perioperative recordings in patients who undergo therapeutic
DBS lead placement procedures that target the STN, using the
implanted DBS electrodes as recording electrodes. It is worth
noting that the (usually bipolar) “LFP” recordings in these cases
refer to potentials between two contacts of the DBS electrode
which are at least 1.5 mm apart, thus reflecting potential
differences between separate groups of neurons. It is not clear
how such potentials relate to the membrane potential fluctuations
in small groups of neurons that are usually recorded as LFPs
in animal experimentation. These studies have shown that the
disease is associated with prominent oscillations in the STN
in the beta band (for review, see Stein and Bar-Gad, 2013)
which can be reduced by dopaminergic medications and high-
frequency stimulation of the STN (Brown et al., 2001; Levy et al.,
2002a; Priori et al., 2004; Wingeier et al., 2006; Kühn et al.,
2008b; Bronte-Stewart et al., 2009). Some of the studies in 6-
OHDA treated rats have also shown increased beta band power
in STN LFPs, as compared with normal animals (Sharott et al.,
2005a).
However, beta-band oscillations in LFP recordings from
MPTP-treated monkeys are not as prominent as they are
in humans (despite the presence of a clearly recognizable
parkinsonism, Devergnas et al., 2014). Explanations for the
discrepancy between these studies and those in human patients
include the possibility that the degree of synchrony in the
parkinsonian monkeys may not be sufficient to lead to recordable
LFP oscillations or that the recording conditions are substantially
different. Another important consideration is that the main
frequency of normal and abnormal oscillations in these animals
may differ from that in humans. It has been suggested that the
8–15 Hz frequency range in monkeys may be equivalent to the
beta band in humans (Stein and Bar-Gad, 2013).
The interactions between the reciprocally connected GPe
and STN (Smith et al., 1998) may be particularly important
in the development of bursts and oscillations in these two
structures (Plenz and Kitai, 1999; Ni et al., 2000a; Cruz et al.,
2011). Modeling studies have proposed that the STN-GPe
connections may generate rhythmic or irregular patterns of
activity. Increased input from indirect pathway MSNs onto GPe
neurons tends to promote rhythmicity and abolish irregular
firing (Terman et al., 2002). After dopamine depletion, the
pallidosubthalamic circuits are strengthened by an increase in
the number of synaptic connections between GPe terminals
and STN, as has been demonstrated in 6-OHDA treated
rodents (Fan et al., 2012). Such increased inhibition from
the GPe may promote hyperpolarization-induced rebound
bursting of STN cells (Beurrier et al., 1999; Bevan et al.,
2007), and account for changes in the temporal structures
of burst discharges in pallidum and STN in MPTP-treated
monkeys (Wichmann and Soares, 2006). Furthermore, studies on
parkinsonian rats have suggested that oscillations that originate
in striatum, cortex or thalamus may be amplified in the GPe-
STN network which would act as a non-linear oscillator with
self-adjusting resonance frequencies (Nevado-Holgado et al.,
2014).
Rhythmic activity in the STN is closely related to that in
cortex (Magill et al., 2000), and this correlation is exacerbated
after dopamine depletion in 6-OHDA treated rats (Magill et al.,
2001), with a peak coherent activity between cortex and STN in
the beta range (Sharott et al., 2005b). Similarly correlated cortex-
STN activity has been described to be dopamine-dependent in PD
patients (Williams et al., 2002; Shimamoto et al., 2013).
GPi AND SNr
As could be predicted by the increased firing of STN neurons and
the reduced firing of GPe neurons, the firing rates of GPi and SNr
neurons are increased after dopamine depletion in most studies of
parkinsonian primates (Figure 3, Miller and DeLong, 1987, 1988;
Filion and Tremblay, 1991; Wichmann et al., 1999; Heimer et al.,
2002; Soares et al., 2004). In PD patients, the average firing rate of
GPi neurons was similar to that seen in MPTP-treated monkeys
(Hutchison et al., 1994; Sterio et al., 1994), and it was higher
than the average discharge rate in dystonia patients (Starr et al.,
2005).
Compared to normal animals, in the GPi of MPTP-treated
monkeys, there was a smaller proportion of neurons that
decreased activity during movement onset (Leblois et al., 2006).
Instead, the authors found that most GPi neurons showed
increased activity around the time of movement. (Leblois
et al., 2006). This abnormal movement-related excitation of GPi
neurons could result in excessive inhibition of thalamic neurons
(and thus, help explain bradykinesia during voluntary movements
in parkinsonism).
GPi neurons of MPTP-treated monkeys also show increased
oscillations and bursting activities (Raz et al., 2000; Soares
et al., 2004; Leblois et al., 2007). Similarly, in PD patients burst
firing is found in both oscillatory and non-oscillatory GPi cells
(Chan et al., 2011). As found in GPe, synchronized activity
among GPi neurons is more prominent after MPTP treatment
in monkeys (Nini et al., 1995; Bergman et al., 1998; Raz et al.,
2000; Morris et al., 2005; Leblois et al., 2007) and in PD patients
(Hurtado et al., 1999; Levy et al., 2000). In studies of LFP signals,
recorded from DBS electrodes in GPi patients (Silberstein et al.,
2003; Weinberger et al., 2006), the relative power in the beta
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band (11–30 Hz) was higher in parkinsonian patients than in
those with dystonia, while the power in the 4–10 Hz range
was higher in the dystonic group (Silberstein et al., 2003). In
MPTP-treated monkeys, however, the oscillatory activities are
predominant at lower frequencies (7.8–15.5 Hz, Devergnas et al.,
2014).
Oscillatory activities can also be identified in the SNr in
6-OHDA treated rats. Recordings using chronically placed
electrodes in the SNr of unilaterally 6-OHDA lesioned animals
showed increased oscillatory LFP activity and increased
synchronization (entrainment) of single cell activity to LFP
oscillations in the 12–40 Hz range in the dopamine-depleted
hemisphere compared to the non-lesioned side (Avila et al.,
2010; Brazhnik et al., 2012, 2014). Brazhnik et al. found
that “active” states, such as grooming and walking, were
related to relatively higher frequencies, while rest and REM
sleep were associated with lower frequencies (Brazhnik et al.,
2014).
While it is not clear how such oscillations are generated or
modulated, the finding of high coherence of oscillations among
STN, GPe and GPi in parkinsonian individuals (Moran et al.,
2012) suggests that the oscillations in the basal ganglia output
nuclei may be related to oscillations in the other nuclei. For
instance, in PD patients, low frequency stimulation of the STN
enhances the synchronization at similar frequencies in the GPi,
while higher frequency stimulation of STN suppresses the beta-
range oscillations in GPi (Brown et al., 2004). It is conceivable
that the altered balance between direct and indirect pathways in
the parkinsonian state (Mallet et al., 2006) may allow (oscillatory)
STN output to strongly “drive” GPi neurons.
There is evidence that, after dopaminergic depletion, there is
a disruption of the somatory-sensory representation in the GPi,
as indicated by a reduction in the specificity of responses to
sensory stimuli in the entopeduncular nucleus of MPTP-treated
cats (Rothblat and Schneider, 1995) and an increased number of
GPi neurons that respond to movement in monkeys (Leblois et al.,
2006).
THALAMUS
Studies in MPTP-treated (parkinsonian) monkeys suggest that
metabolic activity is increased in VA and VL (Mitchell et al.,
1989; Rolland et al., 2007), perhaps reflecting increased basal
ganglia input. The downstream effects of abnormal basal ganglia
output on firing rates in thalamus have been studied to a
limited extent and comparative studies of neuronal activity in
the basal ganglia-receiving regions of the thalamus have been
inconsistent. While some studies show decreased neuronal firing
(Vitek et al., 1994; Schneider and Rothblat, 1996; Ni et al.,
2000b; Kammermeier et al., 2014), others found no firing rate
change (Pessiglione et al., 2005), and others show increase
in firing rates (Bosch-Bouju et al., 2014). In PD patients,
neurons in the basal ganglia-receiving areas of thalamus have
a reduced mean firing rate, compared to similar recordings
from non-PD patients (Molnar et al., 2005; Chen et al.,
2010).
Recent studies in rats have shown that, under normal
conditions, the firing rate of neurons in the motor thalamus
is modulated during reaching movements, and that the
responsiveness of thalamic cells during such movements is greatly
reduced in 6-OHDA lesioned (Bosch-Bouju et al., 2014). Such
task-related changes in thalamic activity could contribute to some
of the deficits in motor performance in parkinsonism.
Studies in MPTP-treated monkeys have suggested that burst
discharges are increased in the motor thalamus (Guehl et al.,
2003; Pessiglione et al., 2005) and a similarly high incidence
of burst firing has been found in corresponding areas in PD
patients (Zirh et al., 1998; Magnin et al., 2000; Molnar et al.,
2005). The thalamic bursts were shown to fulfill the criteria of
“rebound” bursts (Magnin et al., 2000), suggesting that the bursts
could result from hyperpolarization of thalamic neurons driven
by increased inhibitory basal ganglia input via a T-type calcium
channel dependent mechanism. These results may, however, not
only relate to the changed motoric state of the subject, but also
to parkinsonism-related changes in the state of arousal. Indeed,
patients and animals tend to be less awake in the parkinsonian
state, which, independent of other factors, may contribute to
the finding of a higher incidence of burst discharges in the
thalamus.
Reports of the effects of parkinsonism on oscillatory activity
in the motor thalamus have been inconsistent. LFP recordings
from the pallidal receiving area of PD patients with drug-
resistant tremor showed prominent oscillations in the tremor
frequency range (4–9 Hz), strongly correlated with oscillations
recorded in frontal cortex (Sarnthein and Jeanmonod, 2007). Our
recent findings on oscillatory activity patterns in parkinsonian
monkeys suggest that single-cell oscillatory activities increase in
the 3–13 Hz range of frequencies, and are mildly reduced in the
gamma-range of frequencies in the basal ganglia-receiving area of
the thalamus (Kammermeier et al., 2014).
The disruption in somatosensory representation is also
apparent in the motor thalamus. The sensory responses of VA/VL
neurons were found to be less specific in MPTP-treated monkeys
than under normal conditions (Pessiglione et al., 2005). In the
thalamus of these animals, the spiking activity of neighboring
VA/VL neurons was more frequently correlated than under
normal conditions (Pessiglione et al., 2005).
Several of the alterations in firing described in the basal
ganglia-receiving portion of the thalamus in parkinsonism, such
as increased bursting and abnormal sensory processing, have also
been described for the thalamic regions that receive cerebellar
inputs (Guehl et al., 2003; Molnar et al., 2005; Pessiglione et al.,
2005; Chen et al., 2010). In fact, a recent study of single unit
activity in the cerebellar and basal ganglia-receiving regions of
the thalamus in PD patients, found that oscillations of single
neurons in the beta range were prominent in the cerebellar
regions of the thalamus, but not in the basal ganglia area (Basha
et al., 2014). The recently described interconnections between
the cerebellum and the basal ganglia (Bostan et al., 2010, 2013;
Bostan and Strick, 2010) could have a role in the development
of electrophysiological alterations and the parkinsonian motor
deficits (Lewis et al., 2013), but it is also possible that such
oscillations reflect changes in cortical oscillatory patterns which
may then be fed back to the thalamus via corticothalamic
projections that modulate the excitability of thalamocortical
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neurons. It is important to note that interventions aimed at
the cerebellar receiving thalamus (lesioning or stimulation) are
an established treatment for parkinsonian tremor, suggesting
that the cerebello-thalamo-cortical pathway may be involved in
the generation of parkinsonian tremor (Benabid et al., 1991;
Schuurman et al., 2000).
Besides the VA/VL, the CM/PF nuclei also receive inputs
from the basal ganglia, and then send a massive projection back
to the striatum (Smith et al., 2014a). The impact of CM/PF
activity on basal ganglia functions under normal conditions is
just starting to emerge (Smith et al., 2011), and remains almost
unexplored in the parkinsonian state. In 6-OHDA treated rats,
recordings in the PF (the rodent equivalent of the primate
CM, Smith et al., 2004) there is a reduction in the number of
neurons with spontaneous activity, a large proportion of cells
develop oscillations at 0.3–2.5 Hz, and there is a reduction in
low threshold spike (LTS) bursts (Parr-Brownlie et al., 2009).
The changes in PF neurons, however, do not seem to be
driven by changes in the basal ganglia (Parr-Brownlie et al.,
2009). LFP recordings in the CM in PD patients described
an increase in gamma band activity after levodopa treatment
and a decrease in beta-band activity, but the latter was seen
in only one of three patients (Kempf et al., 2009). CM/PF
activity changes may not only be shaped by altered inputs
from the basal ganglia, but also by the fact that CM and PF
neurons degenerate early in parkinsonism, as reported for PD
patients (Henderson et al., 2000a,b), and MPTP-treated monkeys
(Villalba et al., 2014). It is unclear how the loss of CM/PF
neurons affects the activity of the remaining cells in the CM/PF
complex or in other basal ganglia structures that receive afferents
from it.
CORTEX
Early studies of neuronal activity of cortical neurons in primary
motor (M1) or supplementary cortices in monkeys reported that
the spontaneous activity of these neurons did not change with
MPTP treatment, but that movement-related discharges were
reduced in parkinsonian animals (Doudet et al., 1990; Watts and
Mandir, 1992; Goldberg et al., 2002; Escola et al., 2003). A later
study, in which M1 projection neurons were identified in primates
on the basis of responses to antidromic stimulation, demonstrated
that the observed reductions in firing rates were restricted to
neurons projecting to the pyramidal tract, but did not affect
those projecting to the striatum (Pasquereau and Turner, 2011).
This suggests that the pyramidal tract projecting subpopulation of
cortical neurons might be particularly involved in the expression
of motor problems associated with parkinsonism.
In M1 of MPTP-treated monkeys, the number of bursting
neurons is increased compared to normal animals (Goldberg
et al., 2002). As reported for the changes in firing rates,
corticospinal, but not corticostriatal, M1 neurons showed
increased bursting after MPTP-treatment (Pasquereau and
Turner, 2011). Increased neuronal synchrony has also been found
among M1 neurons in MPTP treated monkeys (Goldberg et al.,
2002).
In addition to the aforementioned single neuron recording
studies, there is a large number of studies of cortical field
potential oscillations, mostly using EEG and ECoG recordings.
It is noteworthy that EEG signals are the only electrophysiologic
signals from human patients for which true control data (from
normal individuals) are available. The amplitude of these signals
tends to be larger and more robust than similarly recorded LFP
signals recorded from the basal ganglia because of the laminar
organization of cortex that contrasts with the non-laminar
architecture of the basal ganglia. Studies of EEG recordings have
found abnormally large delta (1–3 Hz) and theta band (4–7 Hz)
activities in parkinsonian patients at rest, both in M1 (Soikkeli
et al., 1991; Neufeld et al., 1994; Serizawa et al., 2008) and in
other cortical regions (Silberstein et al., 2005; Babiloni et al., 2011;
Morita et al., 2011). Animal studies have shown an increase of beta
band oscillations in ECoG signals recorded in the frontal cortex of
6-OHDA treated rats (Sharott et al., 2005b; Brazhnik et al., 2012),
and an increase of low frequency oscillations (<15.5 Hz) in M1 of
MPTP treated monkeys (Devergnas et al., 2014).
These cortical activity changes could be secondary to the
aberrant activity in the basal ganglia and thalamus, but could also
originate in the cerebral cortex itself, perhaps reflecting the effects
of cortical dopamine depletion (Lindenbach and Bishop, 2013).
In addition, the effects of the loss of other neurotransmitters (such
as noradrenaline, acetylcholine and serotonin) (Gaspar et al.,
1991; Braak et al., 2003) and the neuronal degeneration in the
motor cortex in PD (MacDonald and Halliday, 2002) remain to
be further studied.
ROLE OF DOPAMINE IN DEVELOPMENT OF
ELECTROPHYSIOLOGICAL CHANGES IN PARKINSONISM
Although it is often mentioned that the changes in
electrophysiologic activity that were discussed above are
consequent to the loss of dopamine in the striatum, the link
between the disrupted striatal dopaminergic transmission and
altered activity patterns in basal ganglia, thalamus and cortex is
not entirely clear. Several studies have attempted to investigate
this issues using locally or systemically administered dopamine
receptor agonists or antagonists.
In PD patients, systemic infusions of therapeutic effective
doses of the non-selective dopamine agonist apomorphine was
shown to decrease the firing rates of GPi cells, and of STN
cells with activity related to limb tremor; it also decreased the
proportion of STN and GPi cells with responses to passive
movements (Levy et al., 2001). However, in other studies,
dopamine receptor agonist treatment did not fully reduce burst
firing in basal ganglia neurons of parkinsonian animals or patients
(Tseng et al., 2000; Lee et al., 2001; Levy et al., 2001), and was
shown to even promote neuronal bursting when locally applied
in the STN (Baufreton et al., 2003; Galvan et al., 2014) or in
GPi or SNr (Kliem et al., 2007). Furthermore, acute blockade of
dopaminergic transmission failed to increase beta band activity in
subthalamic LFPs of rats, despite the presence of motor symptoms
(Mallet et al., 2008b).
While increased bursting in the parkinsonian state may not
fully respond to dopamine replacement, the increased synchrony
found among striatal MSNs, or between MSNs and GP neurons
appears to be more tightly controlled by the presence or absence
of dopamine (Heimer et al., 2002; Burkhardt et al., 2007),
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suggesting that the asynchronous firing of basal ganglia neurons
in the normal state is an actively maintained state. Details of the
mechanism and extent of this identified decorrelating function of
dopamine are lacking.
The effects of dopamine on oscillatory activity patterns
have also been examined. Increased oscillations in the SNr
in the 25–40 Hz become prominent after complete, but not
partial, 6-OHDA lesions, suggesting that an extensive lesion of
the dopaminergic system is a prerequisite for the appearance
of increased oscillatory activity (Quiroga-Varela et al., 2013).
Importantly, motor impairments are evident at early stages of
the dopaminergic degeneration processes. Thus, the increased
oscillatory activity may not be an indicator (or cause) of early
parkinsonism.
Systemic administration of dopaminergic agents reduces the
degree of beta band oscillations in LFP recordings from the STN
and GP in parkinsonian patients (Brown et al., 2001; Cassidy
et al., 2002; Levy et al., 2002a; Priori et al., 2004; Kühn et al.,
2008a; Bronte-Stewart et al., 2009), and from the SNr in 6-OHDA
treated rats (Brazhnik et al., 2014). These agents also restore, to
some extent, EEG abnormalities in M1 in MPTP-treated monkeys
(Devergnas et al., 2014). Interestingly, in the latter study, it was
observed that beta-band activity in the STN was reduced even
in the absence of primary pathologic oscillations, suggesting that
levodopa may not specifically normalize pathologic oscillations
in the parkinsonian state, but may more generally suppress beta-
band oscillations.
As already mentioned, the lack of dopamine is (directly
or indirectly) accompanied by long-term morphological (and
potentially functional) changes at different levels of the basal
ganglia-thalamo-cortical circuits that may contribute to the
abnormal electrophysiologic activities. These morphological
changes are not necessarily a direct consequence of the
dopaminergic loss, and may therefore escape the regulation of
acute dopaminergic interventions.
RELATIONSHIP BETWEEN THE DIFFERENT PATTERN
ABNORMALITIES AND THE BEHAVIORAL MANIFESTATIONS
OF PARKINSONISM
There is little question that neuronal activities in the basal ganglia-
thalamo-cortical circuits are altered in PD, but it is less clear
to what extent these alterations account for the motor (or non-
motor) symptoms of the disease.
One experimental approach to this problem has been to
examine the effects of inactivation of the dysfunctional brain
region(s). Experimental and clinical evidence indicate that lesions
or inactivation of the “overactive” STN or GPi ameliorate
parkinsonian symptoms in parkinsonian animals and in PD
patients (Bergman et al., 1990; Aziz et al., 1991; Guridi et al.,
1994; Wichmann et al., 1994; Parkin et al., 2001; Alvarez
et al., 2005; Coban et al., 2009; Yoon et al., 2014). The
knowledge gained from such lesioning experiments is limited,
however. One problem is that lesions disrupt all activity in
the lesioned nucleus, thus providing little insight into the role
of specific activity changes. A more general consideration is
that improvement of a behavioral abnormality after a lesion
does not necessarily confirm that activity in the lesioned brain
region was a primary cause for the abnormal behavioral patterns.
For instance, the lesion could have induced plastic changes in
other brain regions that could be responsible for the behavioral
improvement.
An alternative way to study the possible link(s) between the
basal ganglia abnormalities and parkinsonism is to examine the
temporal relationship between the electrophysiologic changes
and the behavioral state. An early study in monkeys in which
repeated injections of small doses of MPTP resulted in the gradual
development of parkinsonian signs suggested that changes in
single cell firing in STN and GPi may precede the onset of
motor signs (Bezard et al., 1999). This report contrasts, however
with a more recent report which found activity changes in
GPi only after the development of parkinsonian motor signs
(Leblois et al., 2007). A related study by Sharott et al. (2014)
found that the beta-band power of single- or multiunit activities
recorded in the STN of parkinsonian patients was correlated
with the severity of bradykinesia, and that sub-beta (<2–13 Hz)
oscillations had a positive correlation with bradykinesia and
axial symptoms. Measures of burst intensity (e.g., the intra-
burst firing rate) were also correlated with parkinsonian signs
(Sharott et al., 2014). Interestingly, the severity of tremor
did not correlated with any of the measured abnormalities.
In our own recent study of parkinsonism-related changes in
LFP activities in the basal ganglia of chronically MPTP-treated
monkeys, we did not find a correlation between oscillatory
activity in the STN and motor impairments, but found instead
that the severity of the motor signs was correlated with an
increase in LFP power in low frequency bands (7.8–15.5 Hz)
and a decrease in higher-frequency bands (23.4 Hz) in M1
and GPi. We also found an increase in coherence between M1
and basal ganglia oscillations in the 7.8–23.3 Hz frequency
range to be associated with the severity of parkinsonism
(Figure 4, Devergnas et al., 2014). Thus, it remains unclear
if the early motor parkinsonian signs appear before the
electrophysiological alterations can be detected (Quiroga-Varela
et al., 2013).
Another approach to the possible link between neuronal
activity changes and the motor signs is to analyze whether
effective antiparkinsonian treatments are accompanied by
“normalization” of activity patterns in the basal ganglia-
thalamocortical circuit. Many studies have provided evidence
that antiparkinsonian treatments reduce burst discharges (Filion
et al., 1991; Shi et al., 2006; Xu et al., 2008), beta band
oscillations (Brown et al., 2001; Levy et al., 2002a; Priori
et al., 2004; Wingeier et al., 2006; Kühn et al., 2008b; Bronte-
Stewart et al., 2009; Brazhnik et al., 2014) and abnormal
synchronization within and among basal ganglia nuclei (Levy
et al., 2000; Heimer et al., 2002; Hammond et al., 2007).
Similarly, cortical coherence in the 10–35 Hz range, associated
with the severity of parkinsonism, is reduced with STN-DBS
(Silberstein et al., 2005). DBS in the STN also reduces neuronal
entropy (a measure of the “disorder” of neuronal firing) in
the GPe, GPi and motor thalamus (Dorval et al., 2008).
These correlations obviously do not prove causality, however.
Indeed, other studies have reported that these treatments do
not always completely restore normal electrical activity in basal
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FIGURE 4 | Relationship between oscillatory activity changes in the
cortico-basal ganglia network and progression of parkinsonism, in an
MPTP-treated monkey. The animal was chronically instrumented for
recording of EcoG signals from the primary motor cortex (M1). In addition,
local field potential signals were recorded from STN and GPi through
macroelectrodes that were repeatedly inserted into the same basal ganglia
locations throughout the course of the experiment. (A) Temporal progression
of the development of parkinsonism induced by MPTP injections, based on
weekly evaluations. The solid black line shows the stage of parkinsonism. The
cumulative dose of MPTP is shown as a gray line with open circles, where
each circle corresponds to a single MPTP injection. Stages 1–3 represent
mild, moderate, and moderately-severe parkinsonism, as judged by a
parkinsonian rating scale. (B) Relative spectral power (mean ± SEM) of M1,
STN and GPi signals (EEG, LFPs) across the different stages. (C) Coherence
between M1 and STN, STN and GPi, and M1 and GPi signals in the
7.8–15.5 Hz frequency range across different stages of parkinsonism during
periods of wakefulness. *p < 0.05 vs. baseline (2-way ANOVA with post hoc
Holm-Sidak test). Modified from Devergnas et al. (2014), with permission.
ganglia neurons (Lee et al., 2001; Levy et al., 2001; Heimer
et al., 2006; Hahn et al., 2008; McCairn and Turner, 2009),
or, as already mentioned, that the anti-oscillatory properties of
dopaminergic treatments may be non-specific (Devergnas et al.,
2014).
Finally, it has been studied whether parkinsonian signs can be
induced or worsened by experimentally imposing “pathological”
frequencies or patterns on the basal ganglia circuitry. As in
other studies described above, these studies have not been fully
conclusive. Thus, while low-frequency stimulation of the STN,
presumably inducing beta-band oscillations, was described to
worsen akinesia (Timmermann et al., 2004), other human and
animal studies have found subtle or no effects of this intervention
(Chen et al., 2007, 2011; Eusebio et al., 2008; Syed et al., 2012).
As an alternatively experimental approach to induce parkinsonian
symptoms, Soares et al. (2004) used ibotenic acid to lesion the
GPe in normal monkeys, with the rationale to mimic the proposed
lack of GPe activity in PD (Figure 1, “Parkinsonism”). Such GPe
inactivation increased the firing of STN and GPi neurons, but did
not result in development of parkinsonian motor signs (Soares
et al., 2004).
Overall, despite significant experimental study, it remains
unclear whether the changes found in the neuronal signals
in the parkinsonian state can be clearly linked with the
emergence of parkinsonism. It is important to remember that
the electrophysiological alterations could be more prominent
during specific phases or types of movements (Brazhnik et al.,
2012, 2014; Lemaire et al., 2012; Quiroga-Varela et al., 2013;
Bosch-Bouju et al., 2014). It also remains to be further clarified
which electrophysiological activity changes are most specific
for PD or its specific signs and symptoms (Sanders et al.,
2013; but see Sharott et al., 2014). Studies of this topic in
advanced human patients are obviously complicated by the fact
that long-term exposure to antiparkinsonian treatments and
non-dopaminergic changes may play significant (and poorly
defined) roles.
USE OF THE INSIGHTS FROM PATHOPHYSIOLOGY STUDIES
TO IMPROVE SURGICAL PD THERAPIES
While a causal link between the electrophysiologic abnormalities
and parkinsonian motor signs remains elusive, our knowledge
of the electrophysiological activities in the basal ganglia and
related structures in PD can, nevertheless, be used to improve
surgical therapies, such as DBS or lesioning approaches. For
example, it may be possible to use the power distribution in
LFP signals as a substitute for the currently used time-consuming
microelectrode recording methods to guide the placement of
DBS electrodes. In studies of intra-operatively recorded LFPs
from DBS electrodes that were advanced towards the STN (Chen
et al., 2006; Miyagi et al., 2009), the beta band power in LFP
signals was found to be maximal at the surgical target in the
dorsal STN (Chen et al., 2006; Miyagi et al., 2009). However, this
technique is at present clearly limited by the low spatial resolution
of LFP signal recordings (Zaidel et al., 2010). A related use of
recordings from DBS electrodes is to choose the best stimulation
contact of already implanted electrodes based on the amount of
beta-band power that can be recorded from them (Ince et al.,
2010).
Another application of our electrophysiologic knowledge is
the use of disease-related electrophysiological characteristics to
regulate DBS parameters in “closed-loop” or “adaptive” feedback
regimes that dynamically adapt the therapy to fluctuations of
disease severity, and may help to prolong the battery life of the
implanted devices by cutting the duty-time of the implanted pulse
generator (for review, see Priori et al., 2013). The potential success
of adaptive DBS for PD has been computationally modeled
(Santaniello et al., 2011), and experimentally demonstrated
in studies that used cortical single neuron activity patterns
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to trigger STN stimulation in parkinsonian monkeys (Rosin
et al., 2011). Of course, in clinical use, LFP-based methods
of adaptive DBS would be more practical. The first attempt
to use LFP characteristics to control stimulation parameters
was recently published, using short-term changes in the beta-
band power of STN LFP signals to trigger STN-DBS in PD
patients (Little et al., 2012, 2013). In these experiments, the
adaptive DBS was at least as effective as continuous DBS.
Interestingly, the duty cycle of closed loop-controlled DBS
progressively shortened in these studies, even over relatively short
stimulation periods, suggesting that plastic changes could be
triggered by this type of intermittent STN stimulation that may
eventually make STN DBS less and less necessary to control the
parkinsonian signs in a given patients. The signal analysis and
control of the DBS device still required an external computer
and the miniaturization and overall power consumption of an
implantable signal sampling, processing and stimulation system
remain important limitations (Starr and Ostrem, 2013). Other
approaches have also been proposed, including specifically the use
of measures of cortical phase-amplitude coupling between beta-
and gamma-band ECoGs signals to trigger DBS (de Hemptinne
et al., 2013), or the use of “coordinated reset” stimulation, a
stimulation regime based on computer modeling, designed to
minimize pathologic synchronization of activity patterns in the
STN and related nuclei (Tass et al., 2012; Adamchic et al.,
2014).
CONCLUSIONS
The literature review presented above shows that similar changes
in neuronal activities (changes in firing rates, increases in
bursting, synchrony and oscillatory activities in the beta range)
have been seen in almost all basal ganglia nuclei, both in PD
patients and in animal models of the disease (Table 1). In fact, PD
remains the only neurologic disease for which this level of detailed
information regarding specific network alterations is available. At
the most general level, the described changes jointly paint the
picture of an altered network state that is disruptive for motoric
and non-motoric functions.
Despite all of the progress that has been made in this field,
there is certainly much need for further investigations of the
role of specific circuit nodes or interactions between them in
producing or relaying the described abnormalities, and of the
link(s) between these changes and the behavioral signs of the
disease. There is clearly also a need for further studies of
the cellular and molecular underpinnings of these changes. In
addition, experimental studies need to pay close attention to the
species differences in the basal ganglia circuits among rodents
(and other smaller mammals) and non-human primates and
patients (Parent, 1986; Smith et al., 2014b).
The potential translational payoff of the accumulated
knowledge of activity changes in the parkinsonian state is
very large. Insights gained from these studies may help us to
develop some of these changes (such as EEG changes) into early
biomarkers for treatment trials in patients, and there are already
many trials underway to use them to guide neuromodulation
therapies such as DBS. Furthermore, knowing how specifically
neuronal activity patterns changes in the parkinsonian state may
help us to develop treatments that specifically address these
activity pattern changes rather than simply replace dopamine as is
currently done. Combined, these efforts promise to translate into
more specific therapies for patients with PD that are both, more
effective and less encumbered by adverse effects than the currently
available treatments.
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